US Patent Issued to Appili Therapeutics on March 25 for "Oral formulations of metronidazole and methods of treating an infection using same" (Canadian, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,236, issued on March 25, was assigned to Appili Therapeutics Inc. (Halifax, Canada).

"Oral formulations of metronidazole and methods of treating an infection using same" was invented by Bernard J. Guarino Jr. (Lodi, N.J.), Jamie L. Doran (Guelph, Canada), Zorana Radovic (Laval, Canada), Kevin Sullivan (Halifax, Canada) and Armand Louis Balboni (Waterford, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnes...